Join the club for FREE to access the whole archive and other member benefits.

PolarityTE

Company focused on discovering, designing and developing a range of regenerative tissue products.

PolarityTE (NASDAQ: PTE) is a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by discovering, designing and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering and material sciences.

The PolarityTE platform technology begins with a small piece of the patient’s own, or autologous, healthy tissue, rather than artificially manipulated individual cells. From this small piece of healthy autologous tissue, the company creates an easily deployable, dynamic and self-propagating product designed to enhance and stimulate the patient’s own cells to regenerate the target tissues. Rather than manufacturing with synthetic and foreign materials within artificially engineered environments, PolarityTE manufactures with the patient’s own tissue and uses the patient’s own body to support the regenerative process to create the same tissue from which it was derived. PolarityTE’s innovative method is intended to promote and accelerate growth of the patient’s tissues to undergo a form of effective regenerative healing.

Visit website: https://www.polarityte.com/

 PolarityTE

 polarityte

 PolarityTE

 UC4CJkGPbcvs1ccL-3-PubhQ

Details last updated 14-Aug-2020

People at PolarityTE

Stephen Milner

Chief Clinical Officer of PolarityTE and prior Director of the Johns Hopkins Burn Centers.

Denver Lough

Founder, Chairman and CEO at PolarityTE.

PolarityTE News

Breakthrough for the generation of fully functional skin tissue

Next Big Future - 09-Jun-2017

SkinTE regenerated full-thickness, organized skin and hair follicles in third degree burn wounds....

Read more...
Topics mentioned on this page:
Regenerative Medicine